A recent event celebrated faculty who had earned promotion and/or the grant of tenure, were appointed to named and endowed professorships or had earned membership in the National Academies or the American Academy of Arts and Sciences.
New research indicates that certain anti-cancer therapies may hasten cellular aging, where changes in the DNA of patients may contribute to greater inflammation and fatigue. The findings are published by Wiley early online in CANCER, a peer-reviewed journal of the American Cancer Society.
Cancer Therapy Can Increase Inflammation, Fatigue, and Cellular Age
Source: National Cancer Institute/Unsplash
May 25, 2021
Share
Chronic fatigue and inflammation are debilitating symptoms in patients with cancer. Anti-cancer therapies may alter epigenetic signatures on the DNA contributing to an acceleration of biological processes of aging, greater inflammation and fatigue, a new study finds.
“Your biological age or the epigenetic age might be different from your chronological age. If your epigenetic age is older than your chronological age, you might age faster, [and be more susceptible to] age-associated adverse conditions. If your epigenetic age is younger than your chronological age, you might age slower,” explains Canhua Xiao, PhD, RN, FAAN, of the Emory University School of Nursing, in Atlanta.
E-Mail
New research indicates that certain anti-cancer therapies may hasten cellular aging, where changes in the DNA of patients may contribute to greater inflammation and fatigue. The findings are published by Wiley early online in
CANCER, a peer-reviewed journal of the American Cancer Society.
Gene activity is often adjusted during life through epigenetic changes, or physical modifications to DNA that do not involve altering the underlying DNA sequence. Some individuals may experience epigenetic age acceleration (EAA) that puts them at a higher risk of age-related conditions than other individuals of the same chronological age. Investigators recently examined EAA changes during and following cancer treatment, and they looked for a potential link between these changes and fatigue in patients with head and neck cancer (HNC).
Cancer treatments might lead to accelerated cellular aging: Study ANI | Updated: May 24, 2021 16:04 IST
Washington [US], May 24 (ANI): The findings of a new research suggests that certain anti-cancer therapies may hasten cellular aging, where changes in the DNA of patients may contribute to greater inflammation and fatigue.
The findings are published by Wiley early online in Cancer, a peer-reviewed journal of the American Cancer Society.
Gene activity is often adjusted during life through epigenetic changes or physical modifications to DNA that do not involve altering the underlying DNA sequence. Some individuals may experience epigenetic age acceleration (EAA) that puts them at a higher risk of age-related conditions than other individuals of the same chronological age.